GMED
Undervalued by 192.2% based on the discounted cash flow analysis.
Market cap | $8.01 Billion |
---|---|
Enterprise Value | $7.71 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.76 |
Beta | 1.33 |
Outstanding Shares | 136,757,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 43.61 |
---|---|
PEG | -3.76 |
Price to Sales | 3.31 |
Price to Book Ratio | 2.05 |
Enterprise Value to Revenue | 3.07 |
Enterprise Value to EBIT | 45.89 |
Enterprise Value to Net Income | 41 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.04 |
No data
No data